Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nolan

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Human Immunology|March 17, 2020
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individualsRebecca Pavlos, Pooja Deshpande, Abha Chopra, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureAndri Rauch, Ian James, Katja Pfafferott, et al.
Immunity|June 14, 2008
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivityDiana Chessman, Lyudmila Kostenko, Tessa Lethborg, et al.
Antiviral Therapy|November 21, 2007
External quality assessment of HLA-B*5701 reporting: an international multicentre surveyEmma Hammond, Coral-Ann Almeida, Cyril Mamotte, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Human Immunology|March 17, 2020
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individualsRebecca Pavlos, Pooja Deshpande, Abha Chopra, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureAndri Rauch, Ian James, Katja Pfafferott, et al.
Immunity|June 14, 2008
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivityDiana Chessman, Lyudmila Kostenko, Tessa Lethborg, et al.
Antiviral Therapy|November 21, 2007
External quality assessment of HLA-B*5701 reporting: an international multicentre surveyEmma Hammond, Coral-Ann Almeida, Cyril Mamotte, et al.
Pageof 11